KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Non-Current Deferred Tax Liability (2016 - 2025)

Amgen (AMGN) has 12 years of Non-Current Deferred Tax Liability data on record, last reported at $1.5 billion in Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 14.79% year-over-year to $1.5 billion; the TTM value through Sep 2025 reached $1.5 billion, down 14.79%, while the annual FY2024 figure was $1.6 billion, 31.35% down from the prior year.
  • Non-Current Deferred Tax Liability reached $1.5 billion in Q3 2025 per AMGN's latest filing, up from $1.4 billion in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $2.4 billion in Q4 2023 and bottomed at $1.4 billion in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 4 years is $1.7 billion, with a median of $1.7 billion recorded in 2024.
  • Peak YoY movement for Non-Current Deferred Tax Liability: grew 25.48% in 2023, then plummeted 31.35% in 2024.
  • A 4-year view of Non-Current Deferred Tax Liability shows it stood at $1.9 billion in 2022, then increased by 25.48% to $2.4 billion in 2023, then tumbled by 31.35% to $1.6 billion in 2024, then decreased by 9.78% to $1.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $1.5 billion in Q3 2025, $1.4 billion in Q2 2025, and $1.5 billion in Q1 2025.